A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India-Reference-Cited by-同舟云学术

A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India

Published:2024-04-01 Issue: Volume: Page:
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Biswas Durba,Basu Debapriya,Nag Arijit,Kumar Jeevan,Datta Suvro Sankha^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12288-024-01763-5.pdf

Reference19 articles.

1. Garratty G (1988) Immune hemolytic anemia induced by drugs. PatholBiol (Paris) 36(10):1237–1245

2. Bub CB, Reis IND, Aravechia MG, Santos LD et al (2018) Transfusion management for patients taking an anti-CD38 monoclonal antibody. Rev Bras HematolHemoter 40(1):25–29

3. Nedumcheril MT, DeSimone RA, Racine-Brzostek SE et al (2021) Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab. J Blood Med 12:327–336

4. Mehta K, Shahid U, Malavasi F (1996) Human CD38, a cell-surface protein with multiple functions. FASEB J 10(12):1408–1417

5. Oostendorp M, Lammerts van Bueren JJ, Doshi P et al (2015) When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy. Transfusion 55(6 Pt 2):1555–62

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time for newer approach in age-old AIHA: Daratumumab?;The Lancet Regional Health - Southeast Asia;2024-06

2. Time for newer approach in age-old AIHA;The Lancet Regional Health - Southeast Asia;2024-04